ZNF280A promotes malignant melanoma development through regulating cell proliferation, apoptosis, and cell cycle

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Malignant melanoma (MM) is a deadly skin cancer with over 300,000 annual cases.
• Understanding MM development mechanisms remains incomplete.
• The role of zinc finger proteins in MM is largely unexplored.

Purpose of the Study:

• To identify novel molecular drivers in malignant melanoma.
• To investigate the role of zinc finger protein ZNF280A in MM pathogenesis.
• To explore ZNF280A as a potential prognostic factor for MM.

Main Methods:

• Quantitative analysis of ZNF280A expression in MM tissues versus adjacent normal tissues.
• In vitro and in vivo experiments involving ZNF280A knockdown in MM cells.
• Assessment of cell proliferation, migration, invasion, cell cycle, and apoptosis.
• Analysis of p53 expression in relation to ZNF280A levels.

Main Results:

• ZNF280A expression is significantly elevated in MM tissues compared to para-carcinoma tissues.
• ZNF280A knockdown suppressed MM cell proliferation, migration, and invasion.
• Reduced ZNF280A levels led to increased apoptosis and cell cycle arrest.
• These effects appear to be mediated through the regulation of p53 expression.

Conclusions:

• ZNF280A is identified as a novel risk factor and driver in malignant melanoma.
• ZNF280A promotes MM development by influencing cell proliferation, migration, invasion, cell cycle, and apoptosis.
• Targeting ZNF280A may offer a potential therapeutic strategy for MM.